secwatch.observer — SEC 8-K summary
======================================

Issuer:     SHOULDER INNOVATIONS, INC. (SI)
CIK:        0001699350
Form:       8-K
Filed at:   2026-08-10T11:09:48+00:00
Accession:  0001699350-26-000054
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shoulder Innovations promotes Jon Osborne to Chief Commercial Officer
---------------------------------------------------------------------

- Jon Osborne promoted to Chief Commercial Officer, effective Aug 6, 2026; previously VP of Commercial Development.
- Osborne joined Shoulder Innovations in Sept 2023; prior 9 years at Smith & Nephew, most recently VP Commercial Marketing for Sports Medicine.
- New role covers all commercial organization, customer experience, and medical education teams.
- CEO Rob Ball cites Osborne's role in go-to-market strategy and scaling adoption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699350/000169935026000054/0001699350-26-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699350/000169935026000054/si-20260810.htm
  HTML page:      https://secwatch.observer/filing/0001699350-26-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer